UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000047298
Receipt No. R000053941
Scientific Title Baerveldt glaucoma implant with two tubes inserted into the vitreous cavity
Date of disclosure of the study information 2022/03/28
Last modified on 2022/03/28 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Baerveldt glaucoma implant with two tubes inserted into the vitreous cavity
Acronym Baerveldt glaucoma implant with two tubes inserted into the vitreous cavity
Scientific Title Baerveldt glaucoma implant with two tubes inserted into the vitreous cavity
Scientific Title:Acronym Baerveldt glaucoma implant with two tubes inserted into the vitreous cavity
Region
Japan

Condition
Condition glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate a new surgical technique designed to increase filtration volume with two parallel tubes and one plate of Baerveldt glaucoma implant
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Phase I,II

Assessment
Primary outcomes Intraocular pressure, Supplementa medical therapy score
Key secondary outcomes Corneal endothelial cell count, intraoperative and early postoperative complications

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Double tube insertion
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Neovascular glaucoma cases
Key exclusion criteria Previous tube shunt surgery
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Masayuki
Middle name
Last name Akimoto
Organization Osaka Red Cross Hospital
Division name Ophthalmology
Zip code 543-8555
Address Osaka Red Cross Hospital
TEL 0667745111
Email masayuki@akimoto3.com

Public contact
Name of contact person
1st name Masayuki
Middle name
Last name Akimoto
Organization Osaka Red Cross Hospital
Division name Ophthalmology
Zip code 543-8555
Address 5-30 Fudegasakicho, Tennojiku
TEL 0667745111
Homepage URL
Email masayuki@akimoto3.com

Sponsor
Institute Osaka Red Cross Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Red Cross Hospital
Address 5-30 Fudegasakicho, Tennojiku, Osaka
Tel 0667745111
Email masayuki@akimoto3.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 10
Results Preoperative IOP
Double: 32.0+-11.33 (4.1),
Single: 29.7+-6.31 (5.7)

At 12 months
Double: 11.8+-2.70 (0.2),
Single: 14.2+-4.05 (1.1)
Results date posted
2022 Year 03 Month 28 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 04 Month 14 Day
Date of IRB
2019 Year 04 Month 28 Day
Anticipated trial start date
2019 Year 05 Month 01 Day
Last follow-up date
2022 Year 03 Month 25 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 03 Month 28 Day
Last modified on
2022 Year 03 Month 28 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053941